Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Stanford University |
---|---|
Information provided by: | Stanford University |
ClinicalTrials.gov Identifier: | NCT00350363 |
Comparison of 1 day versus 1 hour application of topical Zymar.
Condition | Intervention | Phase |
---|---|---|
Ophthalmic Surgery |
Drug: Zymar |
Phase IV |
Study Type: | Interventional |
Study Design: | Non-Randomized, Single Blind, Dose Comparison, Parallel Assignment |
Official Title: | One Hour Preoperative Gatifloxacin |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contact: Christopher Ta, MD | 650-725-6995 |
United States, California | |
Stanford | Recruiting |
Stanford, California, United States, 94304 |
Principal Investigator: | Christopher Ta, MD | Stanford University |
Study ID Numbers: | 5004 |
Study First Received: | July 5, 2006 |
Last Updated: | January 23, 2007 |
ClinicalTrials.gov Identifier: | NCT00350363 |
Health Authority: | United States: Institutional Review Board |
Gatifloxacin |
Anti-Infective Agents Therapeutic Uses Pharmacologic Actions |